Swiss Re has securitized $175 million of notes backed by extreme mortality risk, which is the company's third deal in the last 12 months under its Vita Capital IV program.

Swiss Re Capital Markets was the sole manager and bookrunner on the transaction. Collateral for the Vita IV notes consisted of securities issued by the International Bank for Reconstruction and Development.

Subscribe Now

Access to a full range of industry content, analysis and expert commentary.

30-Day Free Trial

No credit card required. Access coverage of the securitization marketplace, including breaking news updated throughout the day.